TGFB1 and central nervous system cancer: The glioma TME favors recruitment and survival of Tregs by maintaining high concentrations of cytokines that support Treg persistence, such as transforming growth factor-β (TGF-β) and indoleamine 2,3-dioxygenase (IDO) [22, 23].